Summary.
Phenylketonuria (PKU) is an autosomal recessive genetic disease caused by the defects in the phenylalanine hydroxylase (PAH) gene. Individuals homozygous for defective PAH alleles show elevated levels of systemic phenylalanine and should be under strict dietary control to reduce the risk of neuronal damage associated with high levels of plasma phenylalanine. Researchers predict that plant phenylalanine ammonia-lyase (PAL), which converts phenylalanine to nontoxic t-cinnamic acid, will be an effective therapeutic enzyme for the treatment of PKU. The problems of this potential enzyme therapy have been the low stability in the circulation and the antigenicity of the plant enzyme. Recombinant PAL originated from parsley (Petroselinum crispum) chemically conjugated with activated PEG2 [2,4-bis(O-methoxypolyethyleneglycol)-6-chloro-s-triazine] showed greatly enhanced stability in the circulation and was effective in reducing the plasma concentration of phenylalanine in the circulation of mice. PEG-PAL conjugate will be an effective therapeutic enzyme for the treatment of PKU.
Similar content being viewed by others
References
CM Ambrus JL Ambrus C Horvath H Pedersen S Sharma C Kant E Mirand R Guthrie T Paul (1978) ArticleTitlePhenylalanine depletion for the management of phenylketonuria: use of enzyme reactors with immobilized enzymes. Science 201 837–839 Occurrence Handle567372 Occurrence Handle1:STN:280:CSeB2M%2Fjs1Y%3D
M Baedeker GE Schulz (1999) ArticleTitleOverexpression of a designed 2.2 kb gene of eukaryotic phenylalanine ammonia-lyase in Escherichia coli. FEBS Letters 457 57–60 Occurrence Handle10.1016/S0014-5793(99)01000-5 Occurrence Handle10486563 Occurrence Handle1:CAS:528:DyaK1MXmtFejsbs%3D
H Bickel J Gerrard EM Hickmans (1953) ArticleTitleInfluence of phenylalanine intake on phenylketonuria. Lancet 265 812–813 Occurrence Handle13098090 Occurrence Handle1:CAS:528:DyaG2MXhslSitQ%3D%3D
RJ Boscott H Bickel J Scand (1953) ArticleTitleDetection of some new abnormal metabolites in the urine of phenylketonuria. Clin Lab Invest 5 380–382 Occurrence Handle1:CAS:528:DyaG2cXivFWhsg%3D%3D
S Davis A Abuchowski YK Park FF Davis (1981) ArticleTitleAlteration of the circulating life and antigenic properties of bovine adenosine deaminase in mice by attachment of polyethylene glycol. Clin Exp Immunol 46 649–652 Occurrence Handle7337981 Occurrence Handle1:CAS:528:DyaL38XltVaktQ%3D%3D
I Folling (1994) ArticleTitleThe discovery of phenylketonuria. Acta Paediatr [Suppl] 407 4–10 Occurrence Handle1:STN:280:ByqB1cvkt1M%3D
A Gamez L Wang M Straub MG Patch RC Stevens (2004) ArticleTitleToward PKU enzyme replacement therapy: PEGylation with activity retention for three forms of recombinant phenylalanine hydroxylase. Molec Ther 9 124–129 Occurrence Handle1:CAS:528:DC%2BD2cXntVOisA%3D%3D
AF Habeeb (1966) ArticleTitleDetermination of free amino groups in proteins by trinitrobenzene sulfonic acid. Anal Biochem 14 328–336 Occurrence Handle10.1016/0003-2697(66)90275-2 Occurrence Handle4161471 Occurrence Handle1:CAS:528:DyaF28XmvFKitg%3D%3D
EA Havir (1981) ArticleTitlePhenylalanine ammonia-lyase: purification and characterization from soybean cell suspension cultures. Arch Biochem Biophys 211 556–563 Occurrence Handle10.1016/0003-9861(81)90490-2 Occurrence Handle7197898 Occurrence Handle1:CAS:528:DyaL3MXlsVGqsbg%3D
MS Hershfield (1995) ArticleTitlePEG-ADA replacement therapy for adenosine deaminase deficiency: an update after 8.5 years. Clin Immunol Immunopathol 76 S228–S232 Occurrence Handle10.1016/S0090-1229(95)90306-2 Occurrence Handle7554473 Occurrence Handle1:CAS:528:DyaK2MXptFOnsL0%3D
JA Hoskins SB Holiday AM Greenway (1984) ArticleTitleThe metabolism of cinnamic acid by healthy and phenylketonuric adults: a kinetic study. Biomed Mass Spectrom 11 296–300 Occurrence Handle10.1002/bms.1200110609 Occurrence Handle6743769 Occurrence Handle1:CAS:528:DyaL2cXkvVemsL8%3D
Inada Y, Matsushima A, Saito Y, Yoshimoto T, Nishimura H, Wada H (1989) Synthetic polymer-protein hybrids: modification of L-asparaginase with polyethylene glycol. In: Tsuruta T, Nakajima A (eds) Multiphase biomedical materials. VSP, Zeist The Netherlands, pp 153–166
DA Jervis (1960) ArticleTitleDetection of heterozygotes for phenylketonuria. Clin Chim Acta 5 471–476 Occurrence Handle10.1016/0009-8981(60)90054-1 Occurrence Handle14407184 Occurrence Handle1:CAS:528:DyaF3cXhtFWqtr0%3D
K Kawamura T Igarashi T Fujii Y Kamisaki H Wada S Kishimoto (1985) ArticleTitleImmune responses to polyethylene glycol modified L-asparaginase in mice. Int Arch Allerg Appl Immunol 76 324–330 Occurrence Handle1:CAS:528:DyaL2MXksVOrtbs%3D
Layne E (1957) Spectrophotometric and turbidimetric methods for measuring proteins. III Biuret method. In: Colowoic SP, Kaplan NO (eds) Methods in enzymology, vol 3. Academic Press, New York, pp 450–451
WY Lee AH Sehon (1977) ArticleTitleAbrogation of reaginic antibodies with modified allergens. Nature 267 618–619 Occurrence Handle10.1038/267618a0 Occurrence Handle876382 Occurrence Handle1:CAS:528:DyaE2sXlsFSjtbs%3D
CM McKean (1972) ArticleTitleThe effects of high phenylalanine concentrations on serotonin and catecholamine metabolism in the human brain. Brain Res 47 469–476 Occurrence Handle10.1016/0006-8993(72)90653-1 Occurrence Handle4642573 Occurrence Handle1:CAS:528:DyaE3sXot1Kmug%3D%3D
Nakamura RM, Voller A, Bidwell DE (1986) In: Weir DM (ed) Handbook of experimental immunology, vol 27. Blackwell, Oxford, p 1
K Ono Y Kai H Maeda F Samizo K Sakurai H Nishimura Y Inada (1991) ArticleTitleSelective synthesis of 2,4-bis(O-methoxypolyethylene glycol)-6-chloro-s-triazine as a protein modifier. J Biomater Sci Poly Ed 2 61–65 Occurrence Handle1:CAS:528:DyaK3MXit12mt7Y%3D
T Saito Y Kumagai T Hiramatsu M Kurosawa T Sato S Habu K Mitsui Y Kodera M Hiroto A Matsushima Y Inada H Nishimura (2000) ArticleTitleImmune tolerance induced by polyethylene glycol-conjugate of protein antigen: clonal deletion of antigen-specific Th-cells in the thymus. J Biomater Sci Poly Ed 11 647–656 Occurrence Handle1:CAS:528:DC%2BD3cXlvFyqtb4%3D
K Start (1998) ArticleTitleTreating phenylketonuria by a phenylalanine-free diet. Prof Care Mother Child 8 109–110 Occurrence Handle9814366 Occurrence Handle1:STN:280:DyaK1M%2FjtF2juw%3D%3D
JH Walter FJ White (2004) ArticleTitleBlood phenylalanine control in adolescents with phenylketonuria. Int J Adolesc Med Health 16 41–45 Occurrence Handle15148857
KJ Wieder NC Palczuk T Van Es FF Davis (1979) ArticleTitleSome properties of polyethylene glycol: phenylalanine ammonia-lyase adducts. J Biol Chem 254 12579–12587 Occurrence Handle91612 Occurrence Handle1:CAS:528:DyaL3cXisVeq
LI Woolf DG Vulliamy (1951) ArticleTitlePhenylketonuria with a study of the effect upon it of glutamic acid. Arch Dis Child 26 487–494 Occurrence Handle14904091 Occurrence Handle1:CAS:528:DyaG38Xjs1KrsQ%3D%3D
T Yoshimoto H Nishimura Y Saito K Sakurai Y Kamisaki H Wada M Sako G Tsujino Y Inada (1986) ArticleTitleCharacterization of polyethylene glycol-modified L-asparaginase from Escherichia coli and its application to therapy of leukemia. Jpn J Cancer Res 77 1264–1270 Occurrence Handle3102431 Occurrence Handle1:CAS:528:DyaL2sXhtFehtL8%3D
M Zucker (1969) ArticleTitleInduction of phenylalanine ammonia-lyase in Xanthium leaf disks: photosynthetic requirement and effect of daylength. Plant Physiol 44 912–922 Occurrence Handle5799052 Occurrence Handle1:CAS:528:DyaF1MXksFOkt7k%3D Occurrence Handle10.1104/pp.44.6.912
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ikeda, K., Schiltz, E., Fujii, T. et al. Phenylalanine ammonia-lyase modified with polyethylene glycol: Potential therapeutic agent for phenylketonuria. Amino Acids 29, 283–287 (2005). https://doi.org/10.1007/s00726-005-0218-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00726-005-0218-5